Why is a therapeutics waiver extension different to the vaccine waiver?

Health Conversation

English - December 05, 2022 09:54 - 16 minutes - 38.7 MB - ★★★★★ - 1 rating
Medicine Health & Fitness Alternative Health health covid-19 r&d patients vaccines pharmaceutical pharma pharmaceutical industry research & development patient safety Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: What would a TRIPS waiver extension mean for diagnostics?

Next Episode: What is the waiver impact on innovation and pandemic preparedness?

Welcome to Health Conversation. Today we're asking Koen Berden, Executive Director for International Affairs at EFPIA, 'Why is a therapeutics waiver extension different to the vaccine waiver?'. Listen to hear their discussion on the challenge and how we're preparing for the future.

Hosted on Acast. See acast.com/privacy for more information.